Siemens Healthcare and Varian Partner to Advance Diagnostic Imaging and Radiotherapy Systems
By MedImaging International staff writers Posted on 05 Nov 2012 |
A new partnership agreement between Siemens Healthcare (Erlangen, Germany) and Varian Medical Systems (Palo Alto, CA, USA) has been established to advance radiation treatment planning and delivery technology.
A strategic global partnership between Siemens Healthcare and Varian Medical Systems, which took effect October 26, 2012, in North America following an international rollout earlier in 2012, provides cutting-edge diagnostic and therapeutic systems and services for treating cancer with image-guided radiotherapy (IGRT) of systems for imaging and treatment in the global radiation oncology business. This collaboration also includes the development of software interfaces between Siemens and Varian treatment systems. Moreover, the two companies will investigate prospects for joint development of new technology for radiosurgery and IGRT.
Varian will represent Siemens diagnostic imaging products such as computed tomography (CT), positron emission tomography/computed tomography (PET/CT), and magnetic resonance imaging (MRI) to radiation oncology clinics in North America and in most international markets. Similarly, Siemens will represent Varian equipment and software for radiotherapy and radiosurgery within its product range to its healthcare customers. This collaboration enables both companies to offer comprehensive systems that support the complete clinical workflow from imaging to treatment.
Varian and Siemens are also developing interfaces to enable Varian’s Aria oncology information-system software to support Siemens accelerators and imaging systems, providing clinics with more ways to improve workflow and streamlining operations. The collaboration enables Siemens and Varian to codevelop and provide cancer treatment centers with new treatment and imaging systems by utilizing both companies’ technologic expertise.
Offering modulated arc therapy to Siemens’ Artiste linear accelerator, the new mARC software enables precise control of radiation delivery and is up to 65% faster than intensity-modulated radiation therapy (IMRT) for individual treatment that best suits patient needs. mARC enables continuous gantry motion by alternating beam-on, beam-off periods, with fixed apertures during beam-on periods and modified apertures during beam-off periods; treatment can be resumed at any time. Moreover, mARC provides precise delivery control for smooth quality assurance (QA).
Related Links:
Siemens Healthcare
Varian Medical Systems
A strategic global partnership between Siemens Healthcare and Varian Medical Systems, which took effect October 26, 2012, in North America following an international rollout earlier in 2012, provides cutting-edge diagnostic and therapeutic systems and services for treating cancer with image-guided radiotherapy (IGRT) of systems for imaging and treatment in the global radiation oncology business. This collaboration also includes the development of software interfaces between Siemens and Varian treatment systems. Moreover, the two companies will investigate prospects for joint development of new technology for radiosurgery and IGRT.
Varian will represent Siemens diagnostic imaging products such as computed tomography (CT), positron emission tomography/computed tomography (PET/CT), and magnetic resonance imaging (MRI) to radiation oncology clinics in North America and in most international markets. Similarly, Siemens will represent Varian equipment and software for radiotherapy and radiosurgery within its product range to its healthcare customers. This collaboration enables both companies to offer comprehensive systems that support the complete clinical workflow from imaging to treatment.
Varian and Siemens are also developing interfaces to enable Varian’s Aria oncology information-system software to support Siemens accelerators and imaging systems, providing clinics with more ways to improve workflow and streamlining operations. The collaboration enables Siemens and Varian to codevelop and provide cancer treatment centers with new treatment and imaging systems by utilizing both companies’ technologic expertise.
Offering modulated arc therapy to Siemens’ Artiste linear accelerator, the new mARC software enables precise control of radiation delivery and is up to 65% faster than intensity-modulated radiation therapy (IMRT) for individual treatment that best suits patient needs. mARC enables continuous gantry motion by alternating beam-on, beam-off periods, with fixed apertures during beam-on periods and modified apertures during beam-off periods; treatment can be resumed at any time. Moreover, mARC provides precise delivery control for smooth quality assurance (QA).
Related Links:
Siemens Healthcare
Varian Medical Systems
Latest Industry News News
- GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
- Patient-Specific 3D-Printed Phantoms Transform CT Imaging
- Siemens and Sectra Collaborate on Enhancing Radiology Workflows
- Bracco Diagnostics and ColoWatch Partner to Expand Availability CRC Screening Tests Using Virtual Colonoscopy
- Mindray Partners with TeleRay to Streamline Ultrasound Delivery
- Philips and Medtronic Partner on Stroke Care
- Siemens and Medtronic Enter into Global Partnership for Advancing Spine Care Imaging Technologies
- RSNA 2024 Technical Exhibits to Showcase Latest Advances in Radiology
- Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer
- Innovative Collaboration to Enhance Ischemic Stroke Detection and Elevate Standards in Diagnostic Imaging
- RSNA 2024 Registration Opens
- Microsoft collaborates with Leading Academic Medical Systems to Advance AI in Medical Imaging
- GE HealthCare Acquires Intelligent Ultrasound Group’s Clinical Artificial Intelligence Business
- Bayer and Rad AI Collaborate on Expanding Use of Cutting Edge AI Radiology Operational Solutions
- Polish Med-Tech Company BrainScan to Expand Extensively into Foreign Markets
- Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read moreMRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreUltrasound
view channel.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read moreNuclear Medicine
view channel
Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more